NCT03889431 is a NA clinical trial of Iodine capsule in Iodine Deficiency Goiter, sponsored by Oklahoma State University.

Who is sponsoring NCT03889431?

NCT03889431 is sponsored by Oklahoma State University.

What drugs are being tested in NCT03889431?

Interventions in NCT03889431: Iodine capsule, Iodized Salt.

What condition does NCT03889431 study?

NCT03889431 studies Iodine Deficiency Goiter, Infant Development.

Is NCT03889431 still recruiting?

NCT03889431 is currently completed. Last updated 26 March 2019.

Last reviewed 2019-03-26 · How we verify

NCT03889431

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Community Salt Testing and Relation of Iodine Intake to Visual Information Processing of Ethiopian Infants

Completed NA Last updated 26 March 2019

What this trial tests

NA trial testing Iodine capsule in Iodine Deficiency Goiter in 106 participants. Completed in 10 August 2013.

Timeline

2 January 2013

Primary endpoint
30 January 2013

10 August 2013

Quick facts

Lead sponsor	Oklahoma State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	106
Start date	2 January 2013
Primary completion	30 January 2013
Estimated completion	10 August 2013
Sites	1 location across Ethiopia

Drugs / interventions tested

Iodine capsule
Iodized Salt

Conditions studied

Iodine Deficiency Goiter — all drugs for Iodine Deficiency Goiter →
Infant Development — all drugs for Infant Development →

Sponsor

Oklahoma State University

Who can join

Adults 18 to 45, female only, with Iodine Deficiency Goiter or Infant Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluated efficacy of iodized salt for mothers and their six-month-old infants' thyroid hormones and visual information processing. Half of the participants received 450 g iodized salt for the household each week, while the other half received 225 ug iodine daily as a potassium iodide capsule.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Iodine supplementation of lactating women and assessment of infant visual information processing and maternal and infant thyroid function: A randomized trial.
Gebreegziabher T, Woltamo T, Thomas DG, Kennedy TS, et al · · 2019 · cited 7× · PMID 31589645 · DOI 10.1371/journal.pone.0223348

Verify or expand the search:

Other Oklahoma State University trials

Trials by the same sponsor.

NCT06970457 — The Interaction of Body Composition, Sex Hormones and Exercise in Men · NA · recruiting
NCT06840431 — Randomized Control Trial of the Co-Parenting for Resilience Program · NA · enrolling by invitation
NCT05977192 — Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination · NA · completed
NCT06518863 — Ultra-Processed Foods and Executive Function · NA · completed
NCT06310603 — Determinants and Outcomes of High vs. Low Ultra-processed Feeding · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03889431 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oklahoma State University
Last refreshed: 26 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03889431.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing